History has never been kind to Anne Boleyn, calling her a wicked wife, a seductress, and even a witch, and yet, she has ...

Mary Beth Hurt, a Tony Award-nominated actor who appeared in movies including 'The World According to Garp' and Scorsese's ...

A new British-based consortium aims to cut emissions by 60% compared to conventional fossil-derived solvents. Pharma's emissions per dollar of revenue are higher than the car industry. Solvents are a ...

Mary Earps admits the backlash from her book was "a consequence of my own actions" but initially she struggled to understand why she was under so much heat. The ex-Lionesses No.1 sparked huge debate ...

12:06, Wed, Feb 25, 2026 Updated: 12:06, Wed, Feb 25, 2026 Mary Earps has accepted responsibility for her part in the saga that rocked the Lionesses ahead of their Euros triumph last year. Sarina ...

Mary MacKillop, (born January 15, 1842-August 8, 1909) RSJ, also known as Mary of the Cross, was an Australian religious sister. She co-founded the Sisters of St Joseph of the Sacred Heart (the ...

Elizabeth Mary England, age 59, beloved daughter of Loretta O’Connor England and the late James R. England, passed away peacefully at a beautiful hospice center in Edgewater, Florida on February 1, ...

Biography of Hannie Schaft: The 24-year-old Dutch resistance heroine (1920-1945) + Colonel Blood's 1671 theft of England's crown jewels Posted: February 3, 2026 | Last updated: February 3, 2026 Today, ...

Queen Mary II was 1/2 of England’s only joint monarchy, and half of a pair of powerful sister Queens. She betrayed her father and took his throne with the support of her Dutch husband, William of ...

Emily Hay has previously received funding from the Arts and Humanities Research Council (AHRC). The last letter of Mary, Queen of Scots goes on display in 2026 for the first time in almost a decade.

Was Mary the victim of Queen Elizabeth’s dynastic ambitions or the perfidious plotter not only against the English queen but against the English church and the liberties of its populace?

Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients responding with telitacicept versus 32.7% with placebo Dual inhibition of BAFF ...